Maravai LifeSciences Holdings, Inc. (MRVI)

MRVI Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	192.44	259.19	288.95	883	799.24	284.1
Revenue Growth (YoY)	-30.47%	-10.30%	-67.28%	10.48%	181.32%	98.48%
Cost of Revenue	151.9	150.88	148.74	168.96	140.56	79.65
Gross Profit	40.54	108.31	140.2	714.04	658.68	204.45
Selling, General & Admin	154.78	161.77	147.29	125.76	100.06	94.25
Research & Development	18.18	19.22	17.28	18.37	15.22	6.42
Operating Expenses	172.95	180.99	164.57	144.13	115.28	100.67
Operating Income	-132.42	-72.68	-24.37	569.92	543.4	103.78
Interest Expense	-31.7	-47.7	-45.89	-20.41	-30.26	-30.74
Interest & Investment Income	15.09	27.4	27.73	2.34	-	-
Other Non Operating Income (Expenses)	-4.07	-2.38	667.55	-4.46	6.38	0.13
EBT Excluding Unusual Items	-153.09	-95.36	625.02	547.38	519.52	73.17
Merger & Restructuring Charges	-7.39	1.21	-10.57	-3.5	-	-
Impairment of Goodwill	-54.8	-166.15	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	11.25	19
Other Unusual Items	-2.76	-1.18	3.29	7.59	-	-7.59
Pretax Income	-218.04	-261.48	617.74	551.47	530.77	81.7
Income Tax Expense	-4.23	-1.86	756.11	60.81	61.52	2.88
Earnings From Continuing Operations	-213.81	-259.62	-138.38	490.66	469.25	78.82
Minority Interest in Earnings	92.82	114.78	19.35	-270.46	-287.21	10.16
Net Income	-121	-144.85	-119.03	220.21	182.04	88.97
Preferred Dividends & Other Adjustments	-	-	-	-	-	12.08
Net Income to Common	-121	-144.85	-119.03	220.21	182.04	76.89
Net Income Growth	-	-	-	20.97%	104.60%	-
Shares Outstanding (Basic)	144	138	132	132	115	10
Shares Outstanding (Diluted)	144	138	132	255	258	29
Shares Change (YoY)	5.96%	4.54%	-48.33%	-0.96%	791.80%	-88.61%
EPS (Basic)	-0.84	-1.05	-0.90	1.67	1.59	7.43
EPS (Diluted)	-0.84	-1.05	-0.90	1.67	1.56	2.36
EPS Growth	-	-	-	6.97%	-33.73%	-
Free Cash Flow	-66.33	-22.19	60.67	518.89	353.72	126.78
Free Cash Flow Per Share	-0.46	-0.16	0.46	2.03	1.37	4.39
Gross Margin	21.07%	41.79%	48.52%	80.87%	82.41%	71.96%
Operating Margin	-68.81%	-28.04%	-8.43%	64.54%	67.99%	36.53%
Profit Margin	-62.88%	-55.88%	-41.19%	24.94%	22.78%	27.06%
Free Cash Flow Margin	-34.47%	-8.56%	21.00%	58.76%	44.26%	44.63%
EBITDA	-80.98	-24.3	15.89	601.75	568.15	129.62
EBITDA Margin	-42.08%	-9.38%	5.50%	68.15%	71.09%	45.62%
D&A For EBITDA	51.43	48.38	40.25	31.84	24.75	25.84
EBIT	-132.42	-72.68	-24.37	569.92	543.4	103.78
EBIT Margin	-68.81%	-28.04%	-8.43%	64.54%	67.99%	36.53%
Effective Tax Rate	-	-	122.40%	11.03%	11.59%	3.52%
Advertising Expenses	-	3.5	2.9	2.5	1.3	1.2

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q